Body mass index can affect gastrointestinal and genitourinary toxicity in patients with prostate cancer treated with external beam radiation therapy

Doi,Hiroshi; Ishimaru,Fumiko; Tanooka,Masao; Inoue,Hiroyuki; Odawara,Soichi; Takada,Yasuhiro; Niwa,Yasue; Fujiwara,Masayuki; Kamikonya,Norihiko; Yamamoto,Shingo; Hirota,Shozo

doi:10.3892/ol.2013.1658

Body mass index can affect gastrointestinal and genitourinary toxicity in patients with prostate cancer treated with external beam radiation therapy

Authors:
- Hiroshi Doi
- Fumiko Ishimaru
- Masao Tanooka
- Hiroyuki Inoue
- Soichi Odawara
- Yasuhiro Takada
- Yasue Niwa
- Masayuki Fujiwara
- Norihiko Kamikonya
- Shingo Yamamoto
- Shozo Hirota
View Affiliations

Affiliations: Department of Radiology, Hyogo College of Medicine, Nishinomiya, Hyogo 663‑8501, Japan, Department of Clinical Radiology, The Hospital of Hyogo College of Medicine, Nishinomiya, Hyogo 663‑8501, Japan, Department of Urology, Hyogo College of Medicine, Nishinomiya, Hyogo 663‑8501, Japan
Published online on: November 5, 2013 https://doi.org/10.3892/ol.2013.1658
Pages: 209-214

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to determine the impact of obesity on radiation‑induced gastrointestinal (GI) and genitourinary (GU) toxicity. The cases of 54 patients with prostate cancer, treated with three‑dimensional conformal radiation therapy (RT), were reviewed. For each patient, the body mass index (BMI), distance between the prostate and rectum (D) on a computerised tomography scan and the dosimetric parameters of the rectum and bladder in the planning data of RT, were analyzed. GI and GU toxicity was assessed during and following RT. The results of the patients with a BMI of <25 (lower BMI) were compared with those of the patients with a BMI of ≥25 (higher BMI). The higher BMI group exhibited significantly lower doses of V60 and V65 in the rectum than the lower BMI group. No significant differences were found in D and bladder doses between the two groups. The incidence of acute GI and GU toxicity and late GI and GU toxicity were 41.7, 19.4, 35.3 and 5.7% in the lower BMI group, respectively, and 27.8, 27.8, 5.9 and 35.3% in the higher BMI group, respectively. In addition, a significant difference was found in the incidence of late GU toxicity between the two groups. Among patients who underwent RT for prostate cancer, those with higher BMIs had a tendency to show lower incidences of GI toxicity and higher incidences of GU toxicity than patients with lower BMIs. To conclude, an increased effort must be made to reduce rectal doses in patients with lower BMIs. Conversely, increased care for GU toxicity must be provided for overweight patients.

View Figures

View References

1	Garg AK, Mai WY, McGary JE, Grant WH III, Butler EB and Teh BS: Radiation proctopathy in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 66:1294–1305. 2006. View Article : Google Scholar : PubMed/NCBI
2	Elliott SP and Malaeb BS: Long-term urinary adverse effects of pelvic radiotherapy. World J Urol. 29:35–41. 2011. View Article : Google Scholar : PubMed/NCBI
3	Wedlake LJ, Thomas K, Lalji A, Blake P, Khoo VS, Tait D and Andreyev HJ: Predicting late effects of pelvic radiotherapy: is there a better approach? Int J Radiat Oncol Biol Phys. 78:1163–1170. 2010. View Article : Google Scholar : PubMed/NCBI
4	Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A and Amols HI: Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 70:1124–1129. 2008. View Article : Google Scholar
5	Lawton CA, Won M, Pilepich MV, Asbell SO, Shipley WU, Hanks GE, Cox JD, Perez CA, Sause WT, Doggett SR and Rubin P: Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys. 21:935–939. 1991. View Article : Google Scholar : PubMed/NCBI
6	Crew JP, Jephcott CR and Reynard JM: Radiation-induced haemorrhagic cystitis. Eur Urol. 40:111–123. 2001. View Article : Google Scholar : PubMed/NCBI
7	No authors listed. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 854:1–452. 1995.PubMed/NCBI
8	Freedland SJ and Platz EA: Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev. 29:88–97. 2007. View Article : Google Scholar : PubMed/NCBI
9	Hsing AW, Sakoda LC and Chua S Jr: Obesity, metabolic syndrome and prostate cancer. Am J Clin Nutr. 86:s843–s857. 2007.PubMed/NCBI
10	Thomas JA II and Freedland SJ: Obesity and prostate cancer: collateral damage in the battle of the bulge. Front Biosci (Schol Ed). 3:594–605. 2011. View Article : Google Scholar : PubMed/NCBI
11	Zilli T, Nguyen TV, Bahary JP, Chagnon M, Dufresne A and Taussky D: Prognostic impact of abdominal adiposity, waist circumference and body mass index in patients with intermediate-risk prostate cancer treated with radiotherapy. Int J Obes (Lond). 35:1421–1426. 2011. View Article : Google Scholar : PubMed/NCBI
12	Efstathiou JA, Chen MH, Renshaw AA, Loffredo MJ and D’Amico AV: Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer. Cancer. 109:1493–1498. 2007. View Article : Google Scholar
13	Palma D, Pickles T and Tyldesley S; Prostate Cohort Outcomes Initiative. Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancer. BJU Int. 100:315–319. 2007. View Article : Google Scholar : PubMed/NCBI
14	Geinitz H, Thamm R, Mueller T, Jess K, Zimmermann FB, Molls M and Nieder C: Impact of body mass index on outcomes after conformal radiotherapy in patients with prostate cancer. Int J Radiat Oncol Biol Phys. 81:16–22. 2011. View Article : Google Scholar : PubMed/NCBI
15	Efstathiou JA, Skowronski RY, Coen JJ, Grocela JA, Hirsch AE and Zietman AL: Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 71:1302–1308. 2008. View Article : Google Scholar
16	D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ and Wein A: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 280:969–974. 1998.
17	Vargas C, Martinez A, Kestin LL, Yan D, Grills I, Brabbins DS, Lockman DM, Liang J, Gustafson GS, Chen PY, Vicini FA and Wong JW: Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. Int J Radiat Oncol Biol Phys. 62:1297–1308. 2005.
18	Yoshizumi T, Nakamura T, Yamane M, Islam AH, Menju M, Yamasaki K, Arai T, Kotani K, Funahashi T, Yamashita S and Matsuzawa Y: Abdominal fat: standardized technique for measurement at CT. Radiology. 211:283–286. 1999. View Article : Google Scholar : PubMed/NCBI
19	Trotti A, Colevas AD, Setser A, et al: CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 13:176–181. 2003. View Article : Google Scholar
20	Peeters ST, Heemsbergen WD, van Putten WL, Slot A, Tabak H, Mens JW, Lebesque JV and Koper PC: Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys. 61:1019–1034. 2005. View Article : Google Scholar
21	Patil N, Crook J, Saibishkumar EP, Aneja M, Borg J, Pond G and Ma C: The effect of obesity on rectal dosimetry after permanent prostate brachytherapy. Brachytherapy. 8:218–222. 2009. View Article : Google Scholar
22	Susil RC, McNutt TR, DeWeese TL and Song D: Effects of prostate-rectum separation on rectal dose from external beam radiotherapy. Int J Radiat Oncol Biol Phys. 76:1251–1258. 2010. View Article : Google Scholar : PubMed/NCBI
23	Noyes WR, Hosford CC and Schultz SE: Human collagen injections to reduce rectal dose during radiotherapy. Int J Radiat Oncol Biol Phys. 82:1918–1922. 2012. View Article : Google Scholar : PubMed/NCBI
24	Stienstra R, Duval C, Müller M and Kersten S: PPARs, obesity and inflammation. PPAR Res. 2007:959742007. View Article : Google Scholar : PubMed/NCBI